Recurrent miscarriage: Causes, evaluation and ... [2] The clinical use of karyotyping spontaneous ... [3] Future directions of failed implantation and recurrent miscarriage ... [4] An update in recurrent spontaneous ... [5] Immune etiology of recurrent pregnancy loss ... [6] Inflammation and the balance of Treg and Th17 cells in transplant rejection ... [7] Natural killer cells and regulatory T cells in early pregnancy ... [8] Reproductive ... [9] Immune profiling in patients with recurrent ... [10] Autoantibodies and prediction of reproductive ... [11] Autoimmunity and recurrent pregnancy ... [12] Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent ... [13] Joining the immunological dots in recurrent ... [14] Changes and clinical significance of peripheral blood helper T lymphocyte and natural killer (NK) cells in unexplained ... [15] Characterization of the subsets of human NKT-like cells and the expression of Th1/Th2 cytokines in patients with unexplained recurrent ... [16] The Th1/Th2/Th17/Treg paradigm induced by ... [17] IL-10-producing macrophages preferentially clear ... [18] The balance of the immune system between T cells and NK cells in ... [19] The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early ... [20] Variations in T-helper 17 and Regulatory T Cells during ... [21] A physiological role for inducible ... [22] An imbalance in interleukin-17 ... [23] Intravenous immunoglobulin therapy affects T regulatory ... [24] Combined oral prednisolone and ... [25] Low-molecular-weight heparin ... [26] Low molecular weight heparin ... [27] Treatment options and pregnancy outcome in ... [28] Aspirin plus heparin or aspirin ... [29] Progesterone supplementation in women ... [30] The basis and value of currently used ... [31] Intravenous immunoglobulin (IVIG) and ... [32] The effects of immunotherapy ... [33] Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: Is paternal ... [34] Controlled trial of treatment of recurrent spontaneous ... [35] Lymphocyte immunotherapy and its probable ...
No takes yet. Share an insight, caveat, or question.
Roumandeh et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: